Monitoring the quality of conduct of clinical trials: a survey of current practices
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Background There is a little empirical evidence to determine which, if any, monitoring practices best achieve the goals of trial monitoring set forth in ICH E6 under the variable circumstances of different clinical trial settings. Purpose The purpose of this project was to describe current methods of monitoring clinical trials and to explore the rationale for the use of those methods. Methods An electronic survey of known monitoring practices was developed and sent to over 200 organizations involved in conducting clinical research. The survey collected information on institutional demographics, methods of overall study oversight, use of risk-based monitoring and factors that influence assessments of risk, and details on quality assurance and monitoring practices. Results Seventy-nine organizations completed the survey; our analysis included the 65 organizations that indicated they perform clinical trials. Data from the survey indicate that a wide variety of monitoring practices are currently being employed. Eighty-three percent of respondents use centrally available data to evaluate site performance, but only 12% of respondents always or frequently used centralized monitoring to replace on-site visits. Eighty-seven percent of respondents indicated that they always performed on-site visits. This varied by type of organization, with 31% of academic coordinating centers/cooperative groups/government organizations always performing on-site monitoring visits versus 84% of other organizations. The rationale for using a specific monitoring approach does not appear to be based on empirical evidence. Fifty-four percent of respondents stated that ‘usual practice’ determined the frequency with which they conducted on-site monitoring visits. Limitations The overall response rate to our survey was only 30%; thus, we may not have captured the full variance of current monitoring practices, and our responding sample may not be representative. Conclusion These findings underscore the necessity of research to provide an evidence base for monitoring practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ensuring trial validity by data quality assurance and diversification of monitoring methods
Baigent, C., Harrell, F. E., Buyse, M., Emberson, J. R., & Altman, D. G. (2008) · Clinical Trials · doi:10.1177/1740774507087554 · Cited by 163 · cited 1×
“Some have suggested that central monitoring is a practical and sensible means of achieving QA [3,4].”
Background
Cited by
Data fraud in clinical trials.
George, S. L., & Buyse, M. (2015) · Clinical Investigation · doi:10.4155/cli.14.116 · Cited by 126
Detecting fabrication in large-scale molecular omics data
Bradshaw, M. S., & Payne, S. H. (2021) · PLOS ONE · doi:10.1371/journal.pone.0260395 · Cited by 8
Hsieh, S.-F., Yorke-Edwards, V., Murray, M. L., Diaz-Montana, C., Love, S. B., & Sydes, M. R. (2023) · Clinical Trials · doi:10.1177/17407745221143449 · Cited by 5
Metadata
- Authors
- Morrison, B. W., Cochran, C. J., White, J. G., Harley, J., Kleppinger, C. F., Liu, A., Mitchel, J. T., Nickerson, D. F., Zacharias, C. R., Kramer, J. M., & Neaton, J. D.
- Venue
- Clinical Trials
- Publisher
- SAGE Publications
- Published
- 2011-06
- Volume
- 8
- Issue
- 3
- Pages
- 342-349
- ISSN
- 1740-7745 (ISSN-L)
- 1740-7753
- OpenAlex
- W2136028960
- Cited by
- 88
- References
- 1
- FWCI
- 6.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Monitoring the quality of conduct of clinical trials: a survey of current practices. https://app.cochat.ai/papers/10.1177/1740774511402703
- The paper
- Morrison, B. W., Cochran, C. J., White, J. G., Harley, J., Kleppinger, C. F., Liu, A., Mitchel, J. T., Nickerson, D. F., Zacharias, C. R., Kramer, J. M., & Neaton, J. D. (2011). Monitoring the quality of conduct of clinical trials: a survey of current practices. Clinical Trials. https://doi.org/10.1177/1740774511402703
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.